Colin Dayan

Professor of Clinical Diabetes and Metabolism

Cardiff University

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Colin Dayan is a Professor of Clinical Diabetes and Metabolism at Cardiff University, UK. His research focuses on type 1 diabetes, specifically addressing therapeutic options, the dynamics of β-cell function, and innovative treatments for associated conditions such as Graves Orbitopathy. Recent publications highlight his contributions to understanding the diagnosis and progression of diabetes in adult populations, and he advocates for strategies to prevent type 1 diabetes in childhood.

Articles (19)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (9)

Ilaria Muller

Assistant Professor in Endocrinology

University of Milan

ITALY

View details

Shuren LI

Ao. Univ.-Prof. Dr.

Medical University of Vienna

AUSTRIA

View details

Elizabeth McAninch

Stanford University

UNITED STATES

View details

Angus Jones

Associate Clinical Professor

University of Exeter

UNITED KINGDOM

View details

Lakdasa Premawardhana

Hon Professor

Cardiff University School of Medicine

UNITED KINGDOM

View details

Mercedes Rigla

Institute of Research and Innovation Parc Tauli

SPAIN

View details

Kostas Boboridis

Associate Professor in Ophthalmology

Aristotle University of Thessaloniki School of Medicine

GREECE

View details

John Lachin

Professor

George Washington University

UNITED STATES

View details

Matthew Snape

Professor in Vaccinology and Paediatrics

University of Oxford

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Colin Dayan

Research Interests

Explore related searches

Contact this professor

About

Articles (19)

System Failure in Type 1 Diabetes: What Stakeholders Need to Know to Expedite Therapeutic Options

Revisiting the Pattern of Loss of β-Cell Function in Preclinical Type 1 Diabetes

The Race for New Treatments for Graves Orbitopathy (Thyroid Eye Disease)

Evidence for C-Peptide as a Validated Surrogate to Predict Clinical Benefits in Trials of Disease-Modifying Therapies for Type 1 Diabetes

Age of Diagnosis Does Not Alter the Presentation or Progression of Robustly Defined Adult-Onset Type 1 Diabetes

Author Correction: A perspective on treating type 1 diabetes mellitus before insulin is needed

A perspective on treating type 1 diabetes mellitus before insulin is needed

Endocrine and multiple sclerosis outcomes in patients with autoimmune thyroid events in the alemtuzumab CARE-MS studies

Diagnosing Type 1 diabetes in adults: Guidance from the UK T1D Immunotherapy consortium

The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy.

Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial.

Preventing type 1 diabetes in childhood.

Liothyronine and levothyroxine prescribing in England: A comprehensive survey and evaluation.

Trends in costs and prescribing for liothyronine and levothyroxine in England and wales 2011-2020.

A little help from residual β cells has long-lasting clinical benefits.

Announcing the first AoP webinar: 'Can evidence-based medicine survive in a pandemic?'

Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document.

Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document.

Referral rates of patients with diabetes to secondary care are inversely related to the prevalence of diabetes in each primary care practice and confidence in treatment, not to HbA1c level.

Collaborators (9)

Ilaria Muller

Shuren LI

Elizabeth McAninch

Angus Jones

Lakdasa Premawardhana

Mercedes Rigla

Kostas Boboridis

John Lachin

Matthew Snape

Make your next move.